论文部分内容阅读
华北制药厂是1958年建厂的国有特大型企业,国内同行业的“药老大”。然而,随着一些合资企业、特区企业凭借在政策、资金、机制上的优势迅速崛起,“药老大”的地位受到了挑战。1988年至1991年,我国医药行业工业总产值的年平均增长速度为14.86%,而华药仅为4.02%。销售收入、实现利税、人均利税等重要指标,华药也只分别居第二、第三甚至第四位。
North China Pharmaceutical Factory is a state-owned large-scale enterprise established in 1958, and the “medicine boss” in the same industry in China. However, as some joint ventures and SAR companies have rapidly emerged from their advantages in terms of policies, funds, and mechanisms, the status of “medicine bosses” has been challenged. From 1988 to 1991, the average annual growth rate of China’s pharmaceutical industry’s total industrial output value was 14.86%, while Huayou was only 4.02%. As for important indicators such as sales revenue, profits and taxes, per capita tax, China Pharmaceutical also ranks only second, third or even fourth respectively.